People using Metformin show a reduced incidence of cancer compared to those who dont
Combination therapy was significantly associated with 0.68, 0.83, and 0.67 kg/m 2 greater reductions in BMI from baseline at 6, 12, and 18 months, respectively (See Supplementary Fig
Levothyroxine is a textbook narrow-therapeutic-index drug, dosed in micrograms and titrated to a laboratory target
With the recent FDA approval of oral semaglutide specifically for weight management , patients now have a needle-free option that delivers powerful results
Any significant elevation in these markers should prompt clinical correlation and consideration of alternative causes, including medication effects, disease progression, or new hepatic pathology